Green Light for DiabeCell Phase 1
Posted Apr 18th 2007 3:23PM by Allie Beatty
Filed under: Type 1, Childhood, Adult Onset, Drugs, Research, Support
Living Cell Technologies has been given the go ahead to conduct clinical trials of its DiabeCell diabetes product in New Zealand.
DiabeCell is a porcine islet cell product for the treatment of insulin- dependent diabetes. The pig cells are injected into the body without any immunosuppressant drugs. The cells produce insulin to help regulate blood glucose levels appropriate to the amount of glucose detected in the blood stream of the diabetic recipient.
The Medical Director of Living Cell Technologies explains that DiabeCell offers considerable advantages over other available treatments in addition to the fact there is no need for immuno-suppressive drugs. Anther problem of islet transplants is the strain on the supply of islets. This is not a problem with the DiabeCell because their supply of cells derive from natural biocertified pig herds, unlike human organ donors.
LCT's application is to conduct the clinical trial of its DiabeCell product on 8 long standing Type 1 diabetics. The clinical trial is expected to be approximately 12 months in duration. This will then be followed by a trial on a larger scale. The trial will be conducted at a New Zealand hospital and involves the simple injection of encapsulated islets into the abdomen of the diabetic patients. It is anticipated that the trial would start by the end of 2007.
Tags: advances in medicine, AdvancesInMedicine, autoimmune attack, AutoimmuneAttack, automatically detects blood sugar, automatically releases insulin, AutomaticallyDetectsBloodSugar, AutomaticallyReleasesInsulin, biocertified pig, biocertified pigs, BiocertifiedPig, BiocertifiedPigs, c-peptide, c-peptide diabetes complications, c-peptide levels, C-peptideDiabetesComplications, C-peptideLevels, clinical trials, ClinicalTrials, DiabeCell, diabetes advances, diabetes cure with o need for immuno-suppressive drugs, diabetes industry, diabetes investments, diabetes news, DiabetesAdvances, DiabetesCureWithONeedForImmuno-suppressiveDrugs, DiabetesIndustry, DiabetesInvestments, DiabetesNews, glucose detected in the blood, GlucoseDetectedInTheBlood, Health Ministry, HealthMinistry, insulin- dependent diabetes, Insulin-DependentDiabetes, International Diabetes Issues, InternationalDiabetesIssues, islet transplants, islet.org, islets, IsletTransplants, LCT, Living Cell Technologies, LivingCellTechnologies, make money on diabetes, MakeMoneyOnDiabetes, measures blood glucose, MeasuresBloodGlucose, Medical Director, MedicalDirector, natural biocertified pig, natural biocertified pigs, NaturalBiocertifiedPig, NaturalBiocertifiedPigs, New Zealand Health Ministry, NewZealandHealthMinistry, o need for immuno-suppressive drugs, ONeedForImmuno-suppressiveDrugs, pig islets, PigIslets, porcine islet cell, porcine islets, PorcineIsletCell, PorcineIslets, releases insulin, ReleasesInsulin, start by the end of 2007, StartByTheEndOf2007, stop autoimmune attack on the isletes, StopAutoimmuneAttackOnTheIsletes, WHO, without any immunosuppressant, WithoutAnyImmunosuppressant, world health organization diabetes, WorldHealthOrganizationDiabetes, xenotransplants
1. One of the Trade-Offs would be the growth of a snout...............but at least the T1DM would be gone.
Posted at 4:38PM on Apr 18th 2007 by BetterCell